montelukast

Uro Pipeline: Supplemental application submitted for advanced RCC treatmentOther pipeline developments include an agent to control pain in IC/BPS patients, an antibody to treat prostate and bladder cancer, an injectable OAB treatment, and more.
Rethinking asthma: Prevention and management
Rethinking asthma: Prevention and managementDespite significant advances in asthma research and care, the burden of asthma remains high. This article will review a number of different aspects of asthma care that impact the pediatrician.
Adverse effects of montelukast examined by FDA's Pediatric Advisory CommitteeAt its late September meeting, the Pediatric Advisory Committee (PAC) to the US Food and Drug Administration (FDA) said it’s time to remind healthcare professionals that Singulair (montelukast) may have adverse effects on mental and behavioral functions.
Asthma therapy worsens symptoms in some kidsSalmeterol, an inhaled, long-acting beta-2 agonist commonly prescribed to treat asthma in children, can actually worsen symptoms for those with the arginine-16 beta-2 receptor genotype, says new research from the United Kingdom.